Breaking News on Food & Beverage Development - North AmericaEU edition | Asian edition
Supplier info center > Related news headlines
All news headlines forSabinsa CorporationSee also : Supplier info center | All products for Sabinsa Corporation |
 |
Sabinsa rolls out novel Moringa and Boswellia extracts, hails ‘overwhelming response’ to Curcumin C3 Reduct
01-May-2013 - Sabinsa Corporation is launching two novel water-soluble ingredients, one from of Boswellia serrata, called Polybos, and the other called MoringIn from Moringa oleifera.
Is curcumin the next omega-3? Sabinsa expects so with ‘game changing’ Curcumin C3 Reduct
19-Feb-2013 - The final stumbling blocks for the wide use of curcumin have been removed, claims Sabinsa as it launches its ‘next generation’ of curcuminoids offering ‘greater potency, stability and much better bioavailability’.
Sabinsa’s curcumin shows lipid-lowering activity: RCT
19-Sep-2012 - Daily supplements of a curcumin complex were associated with significant reductions in triglyceride levels, say data from a placebo-controlled, randomized, double-blind clinical trial.
Sabinsa receives payment for ForsLean TM infringement
10-Jul-2012 - The three year intellectual property battle between Sabinsa Corporation and Creative Compounds has finally ended, with Sabinsa receiving nearly $150,000 in disgorged profits from Creative Compounds.
Sabinsa scores industry first with patent-pending synbiotic bilayer tablet
14-Mar-2012 - Sabinsa is set to score an industry first this year when it unveils the first bi-layer synbiotic tablet featuring prebiotics in one layer and probiotics in the other.
Sabinsa gets IFS certification for Utah facility
23-Sep-2011 - Sabinsa Corporation’s Utah facility has been International Food Standard (IFS) certified following an audit by Det Norske Veritas (DNV), as the company continues its commitment to quality.
Sabinsa extends patent portfolio to 66 with new selenium forms
09-Sep-2011 - The US Patent and Trademark Office has granted a patent to Sabinsa for selenodipeptides for cosmeceuticals and pharmaceutical applications.
Resveratrol bioavailability boosted by piperine: Study
16-Aug-2011 - Combining resveratrol with piperine may enhance its bioavailability and help translate the potential benefits of the compound to humans, suggests a new study with mice.
NJ District Court awards Sabinsa damages over ForsLean TM infringement
08-Aug-2011 - The US District Court of New Jersey has awarded damages to Sabinsa Corporation following a trademark infringement by Creative Compounds involving Coleus forskohlii extracts.
Selenium sales slump? Our sales are increasing, says Sabinsa
08-Jul-2011 - Selenium supplement sales as a whole may be 14 percent down, but sales of selenium for Sabinsa are growing by a ‘very healthy 36 percent’ year on year, says the company’s marketing director.
Pterostilbene ‘more potent than resveratrol’ for colon health: Study
21-Mar-2011 - Pterostilbene, an ingredient garnering a lot of attention in the natural products industry, is ‘more potent’ than resveratrol for colon health, says a new study.
Supreme Court supports Sabinsa in ForsLean trademark case
11-Feb-2011 - The US Supreme Court has denied Creative Compounds’ Petition for Writ of Certiorari in the protracted battle with Sabinsa Corporation’s over trademark infringement of Sabinsa’s ForsLean.